Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis

Seminars in Hematology · Published 2026-06-01 · DOI 10.1053/j.seminhematol.2026.06.003

Authors (2)

Katherine J. Feder, Gabriela S. Hobbs

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Feder, K., Hobbs, G. (2026). Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis. Seminars in Hematology. https://doi.org/10.1053/j.seminhematol.2026.06.003

Related articles